NeuroStar TMS Therapy in Delta, Utah
FDA-cleared, non-invasive treatment for depression, provided under the psychiatric direction of Dr. Thomas Rayner, MD.
What is TMS Therapy?
TMS (Transcranial Magnetic Stimulation) is an FDA-cleared, non-invasive procedure that uses focused magnetic pulses to stimulate nerve cells in brain regions associated with mood regulation, particularly the left dorsolateral prefrontal cortex. TMS is well-established for adults with major depressive disorder who have not responded adequately to antidepressant medications.1,2
Delta Healing Solutions offers NeuroStar TMS, one of the most widely used TMS systems in the United States. Treatment is delivered under the medical direction of psychiatrist Dr. Thomas Rayner, MD.
Delta Healing Solutions TMS Outcomes
From March 2024 through December 2025, Delta Healing Solutions treated 126 patients with TMS therapy.
82.1%
Clinical response (at least 50% reduction in PHQ-9)
61.3%
Achieved remission (final PHQ-9 of 4 or lower)
93.7%
Completed an adequate course (30+ sessions)
These are Delta Healing Solutions' own clinic outcomes, not published trial averages. Outcomes are tracked using the PHQ-9 as a standardized clinical instrument at baseline and throughout treatment.
Benefits of TMS Therapy
Non-Invasive
No surgery, no anesthesia
No Medication
No systemic side effects
Convenient
Return to normal activities immediately
FDA-Cleared
Backed by 20+ years of research1,2
Insurance Covered
Most plans cover TMS for TRD
Local Follow-Up
PHQ-9 monitoring every 2-3 months after treatment
Who is TMS For?
TMS therapy may be appropriate for you if:
- You have been diagnosed with major depressive disorder (MDD)
- You have not responded adequately to antidepressant medications
- You cannot tolerate the side effects of antidepressants
- You are looking for a non-medication treatment option
- Previous treatments have not provided lasting relief
Contraindications include ferromagnetic implants near the head, active mania, and history of seizure disorder. We screen for these during evaluation.
Not Sure If TMS Is Right for You?
Take a quick 2-minute depression self-check. This screening tool can help identify symptoms and determine if you may benefit from treatment options like TMS.
Take the Self-AssessmentThis is a screening tool and not a diagnosis.
What to Expect
Treatment Schedule
- Daily sessions, Monday through Friday
- Each session lasts approximately 19-37 minutes depending on protocol
- Standard course: 36 sessions over 6-9 weeks
- You can drive yourself to and from appointments
During Treatment
- You sit in a comfortable treatment chair
- The NeuroStar coil is positioned on your head
- You feel a tapping sensation during the session
- You can read, listen to music, or relax
- No recovery time is needed afterward
Results Timeline
- Most patients notice improvement within 2-4 weeks
- Improvement continues to build throughout treatment
- Delta Healing Solutions' clinic outcome: 82.1% of patients achieved clinical response (PHQ-9 reduction of at least 50%)
- PHQ-9 follow-up surveys sent every 2-3 months after treatment to track durability
Side Effects
TMS is well-tolerated with minimal side effects. The most common side effect is mild scalp discomfort or headache during or after treatment, which typically resolves after the first week. Unlike antidepressants, TMS does not cause:
- Weight gain
- Sexual dysfunction
- Nausea or digestive issues
- Drowsiness or sedation
- Memory problems
Are You a Provider?
If you are a primary care provider or psychiatrist considering a referral for TMS, see our provider portal for clinical details and outcomes data. To send a referral: call (435) 864-5151, fax to 435-251-1572, or email info@deltahealingsolutions.org.
References
- Carpenter LL, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety. 2012;29(7):587-596.
- O'Reardon JP, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62(11):1208-1216.